Statera BioPharma OverviewStatera BioPharma Profit Margin
Profitability ratio analysis for STAB.
Quarterly Profit Margin
-769.50%
↑ 85.69% YoY
As of Sep 2022
Annual Profit Margin (TTM)
-2829.37%
↑ 54.20% YoY
Trailing 12 months ending Sep 2022
Average Profit Margin (Comparison Companies)
Profit Margin History
Profit Margin Comparison
Annual Profit Margin Growth Rate (%)